BiotechTube
Home/BioAge Labs/Paul B. Kang
PB

Paul B. Kang

General Counsel

BioAge Labs

Therapeutic Areas

MetabolicCardiovascularOphthalmology

BioAge Labs Pipeline

DrugIndicationPhase
BGE-102Cardiovascular Risk ReductionPhase 1b/2a
Apelin Receptor AgonistObesity (Exercise Mimetic)Preclinical

Leadership Team at BioAge Labs

KF
Kristen Fortney
Chief Executive Officer & Co-Founder
PR
Paul Rubin
Chief Medical Officer
View full BioAge Labs profile